PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0021390|inflammatory bowel disease |
| Sentences | 24 |
| PubMedID- 24462530 | Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: canadian association of gastroenterology. |
| PubMedID- 21455856 | thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance. |
| PubMedID- 21694866 | thromboembolism in inflammatory bowel diseases: a report from saudi arabia. |
| PubMedID- 20472160 | Disease activity and venous thromboembolism in inflammatory bowel disease. |
| PubMedID- 23629820 | Risk of venous thromboembolism in patients with inflammatory bowel disease. |
| PubMedID- 24632349 | Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. |
| PubMedID- 25382207 | Prevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three cases. |
| PubMedID- 20211927 | Risk of venous thromboembolism with inflammatory bowel disease. |
| PubMedID- 24986868 | The incidence of thromboembolic events in patients with inflammatory bowel disease rose from 5.65% in 2000 to 7.17% by 2009. |
| PubMedID- 24703865 | Venous thromboembolism risk in patients with inflammatory bowel disease: defining the benefits of pharmacologic prophylaxis. |
| PubMedID- 22705067 | Background: circulating procoagulant microparticles (mps) are thought to be involved in the pathogenesis of venous thromboembolism in patients with inflammatory bowel disease (ibd). |
| PubMedID- 24552828 | Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. |
| PubMedID- 21339206 | Background: recommendations for venous thromboembolism (vte) prophylaxis in patients with inflammatory bowel disease (ibd) can be refined by incorporating patient-specific risk factors. |
| PubMedID- 24415858 | Hypercoagulability observed in patients with inflammatory bowel diseases (ibd) may lead to thromboembolic events (te), which affect the venous and arterial systems alike and are an important factor in patients' morbidity and mortality. |
| PubMedID- 20472161 | Disease activity and venous thromboembolism in inflammatory bowel disease. |
| PubMedID- 24695669 | Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. |
| PubMedID- 20472163 | Disease activity and venous thromboembolism in inflammatory bowel disease. |
| PubMedID- 24754745 | thromboembolism in inflammatory bowel disease: results from a prospective, population-based european inception cohort. |
| PubMedID- 23549165 | The risk of thromboembolism in inflammatory bowel disease (ibd) is 3-4 fold more than general population[2]. |
| PubMedID- 20472159 | Disease activity and venous thromboembolism in inflammatory bowel disease. |
| PubMedID- 21407182 | Venous thromboembolism in inflammatory bowel disease: an epidemiological review. |
| PubMedID- 23857476 | Duration of anticoagulation for the management of venous thromboembolism in inflammatory bowel disease: a decision analysis. |
| PubMedID- 23550660 | Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. |
| PubMedID- 20824370 | Mesenteric vascular thromboembolism in inflammatory bowel disease: a single center experience. |
Page: 1